Medifast Inc financial data

Symbol
MED on NYSE
Industry
Miscellaneous Food Preparations & Kindred Products
Location
11445 Cronhill Drive, Owings Mills, MD
State of incorporation
DE
Fiscal year end
December 31
Former names
HEALTHRITE INC (to 1/9/2001)
Latest financial report
10-Q - Q3 2024 - Nov 4, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 282 % +54.7%
Quick Ratio 57 % -17.3%
Debt-to-equity 45.1 % -44.4%
Return On Equity 3.55 % -94.8%
Return On Assets 2.45 % -93.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.9M shares +0.42%
Common Stock, Shares, Outstanding 10.9M shares +0.41%
Entity Public Float 1B USD -50%
Common Stock, Value, Issued 11K USD 0%
Weighted Average Number of Shares Outstanding, Basic 10.9M shares +0.41%
Weighted Average Number of Shares Outstanding, Diluted 11M shares +0.35%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 390M USD -5.56%
Revenue from Contract with Customer, Excluding Assessed Tax 674M USD -44.6%
Cost of Revenue 177M USD -49.5%
Operating Income (Loss) 10.8M USD -92.8%
Nonoperating Income (Expense) 1.47M USD +36.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12.3M USD -91.9%
Income Tax Expense (Benefit) 4.99M USD -84.2%
Net Income (Loss) Attributable to Parent 7.33M USD -93.9%
Earnings Per Share, Basic 0.66 USD/shares -94%
Earnings Per Share, Diluted 0.65 USD/shares -94.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 115M USD +2.27%
Cash, Cash Equivalents, and Short-term Investments 173M USD +9.64%
Inventory, Net 40.1M USD -31.1%
Assets, Current 225M USD +0.31%
Deferred Income Tax Assets, Net 4M USD -63%
Property, Plant and Equipment, Net 39M USD -27.1%
Operating Lease, Right-of-Use Asset 12.3M USD -21.6%
Other Assets, Noncurrent 11M USD -30.4%
Assets 291M USD -8.99%
Contract with Customer, Liability, Current 574K USD -92.2%
Liabilities, Current 72.4M USD -34.3%
Operating Lease, Liability, Noncurrent 11.5M USD -31.7%
Liabilities 83.9M USD -33.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 349K USD +148%
Retained Earnings (Accumulated Deficit) 176M USD +4.27%
Stockholders' Equity Attributable to Parent 207M USD +7.41%
Liabilities and Equity 291M USD -8.99%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 7.28M USD -88.6%
Net Cash Provided by (Used in) Financing Activities -1.49M USD +94.2%
Net Cash Provided by (Used in) Investing Activities -2.78M USD -31.2%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 10.9M shares +0.41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.03M USD -91.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 115M USD +2.27%
Deferred Tax Assets, Valuation Allowance 1.68M USD -33.4%
Deferred Tax Assets, Gross 20.5M USD -6.55%
Operating Lease, Liability 17.6M USD -21.1%
Payments to Acquire Property, Plant, and Equipment 1.84M USD -13%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 7.54M USD -93.7%
Lessee, Operating Lease, Liability, to be Paid 18.2M USD -21.8%
Property, Plant and Equipment, Gross 98.8M USD +1.7%
Operating Lease, Liability, Current 6.11M USD +11.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.78M USD -21.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.46M USD +8.51%
Operating Lease, Weighted Average Discount Rate, Percent 0.02 pure 0%
Deferred Income Tax Expense (Benefit) 112K USD -86%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 624K USD -37%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.55M USD -42.5%
Deferred Tax Assets, Operating Loss Carryforwards 2.88M USD -22.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1.5M shares 0%
Unrecognized Tax Benefits 7.5M USD +24.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.62M USD +2.55%
Operating Lease, Payments 1.56M USD -13.4%
Additional Paid in Capital 31M USD +28.6%
Depreciation, Depletion and Amortization 3.26M USD +9.65%
Share-based Payment Arrangement, Expense 7.62M USD -12.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%